SLC6A2 and depressive disorder: G-protein coupled receptors (GPCRs) and neurotransmitter transporters play well-established roles in the pathophysiology of depression and are targets for present antidepressant drugs, and are also recognized targets in the search for more specific and effective pharmacological approaches.